Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

First patient treated in study of DNX-2401 and temozolomide for recurrent glioblastoma

Nov. 15, 2013

Roche and immatics biotechnologies sign cancer vaccine collaboration

Nov. 15, 2013

FDA approves ibrutinib for mantle cell lymphoma

Nov. 14, 2013

UbiVac presents data for its first-in-class lung cancer vaccine

Nov. 14, 2013

Japanese NHI price listing of Kadcyla postponed

Nov. 13, 2013

Innate Pharma presents a novel cytotoxic antibody against KIR3DL2-expressing cancers

Nov. 13, 2013

Mirrx Therapeutics and Centenary Institute enter agreement

Nov. 12, 2013

Researchers report novel replication-competent vesicular stomatitis viruses for cancer

Nov. 12, 2013

Phase II clinical data demonstrate efficacy for an antibody to treat adipocytic sarcoma

Nov. 11, 2013

Prima Biomed grants CVac license to Neopharm for Israel

Nov. 7, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...